Skip to main content
SpringerLink
Log in

Complement in cystic fibrosis

  • Original Investigations
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Complement components C3, C4, and C3A were estimated in 30 patients with cystic fibrosis aged 1 to 21 years (M∶F=16∶14) and were compared with results in 40 healthy, age-matched subjects. The influences of the clinical score, sputum microbiology, and the patients' sex were also investigated. In contrast to most previous communications, this paper shows that, compared to the control group, a significant decrease of C3 (P<0.001) and C4 (P<0.02) was observed whereas C3A levels were not altered. There were no increases in complement. Shwachman-scores above or below 70 did not influence the complement levels, nor did exacerbations of the disease change the levels. No influence of the patients' sex could be shown. Pseudomonas aer. in the sputum was clearly associated with complement defects (14/18). Alternative-pathway involvement of complement activation could be demonstrated in 32%. The results make complement activation due to pulmonary infection most likely. The defects observed probably represent secondary changes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Alper, C. A., Bloch, K. J., Rosen, F. S.: Increased susceptibility to infection in a patient with type II essential hypercatabolism of C3. N. Engl. J. Med. 288, 601–606 (1973)

    Google Scholar 

  2. Alper, C. A.: Alternative or properdin pathway of complement activation. In: The Immune System and Infectious Diseases (eds. E. Neter, F. Milgrom), pp. 479–488. Basel: Karger 1975

    Google Scholar 

  3. Bedrossian, C. W. M., Greenberg, S. D., Singer, D. B., Hansen, J. J., Rosenberg, H. S.: The lung in cystic fibrosis. Human Pathol. 7, 195–204 (1976)

    Google Scholar 

  4. Charlesworth, J. A., Williams, D. G., Sherington, E., Lachmann, P. J., Peters, D. K.: Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemia. J. Clin. Invest. 53, 1578–1587 (1974)

    Google Scholar 

  5. Conover, J. H., Conod, E. J., Hirschhorn, K.: Complement components in cystic fibrosis. Lancet 1973 II, 1501

  6. Conover, J. H., Conod, E. J.: Complement in cystic fibrosis. Lancet 1975 I, 47–48

    Google Scholar 

  7. Conover, J. H., Conod, E. J., Hirschhorn, K.: Studies on ciliary dyskinesia factor in cystic fibrosis. IV. Its possible identification as anaphylatoxin (C3a)-IgG complex. Life Sci. 14, 253–266 (1974)

    Google Scholar 

  8. Danes, B. S., Bearn, A. G.: Cystic fibrosis of the pancreas, a study in cell culture. J. Exp. Med. 129, 775–794 (1969)

    Google Scholar 

  9. Esterly, J. R., Oppenheimer, E. H., Landing, B. H.: Pathology of cystic fibrosis. In: Cystic Fibrosis, Projections into the future (eds. J. A. Mangos, R. C. Talamo), pp. 115–124. New York: Stratton Intercontinental Medical Book Corp. 1976

    Google Scholar 

  10. Fearon, D. T., Ruddy, S., Schur, P. H., McCabe, W. R.: Activation of the properdin pathway of complement in patients with gram-negative bacteremia. N. Engl. J. Med. 292, 937–940 (1975)

    Google Scholar 

  11. Füst, G., Petrás, G., Ujhelyi, E.: Activation of the complement system during infections due to gram-negative bacteria. Clin. Immunol. Immunopathol. 5, 293–302 (1976)

    Google Scholar 

  12. Gibbons, A., Allan, J. D., Holzel, A., McFarlane, H.: Cell-mediated immunity in patients with cystic fibrosis. Brit. Med. J. 1976 I, 120–122

    Google Scholar 

  13. Gibson, L. E., Cooke, R. E.: A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics 23, 545–549 (1959)

    Google Scholar 

  14. Goetz, M., Eibl, M.: Immunological investigations in patients with cystic fibrosis and chronic Pseudomonas infection. 6th Ann. Meeting Europ. Work. Group Cystic Fibrosis. Dublin, June 30–July 1, 1975

  15. Hann, S., Holsclaw, D. S., Shin, H. S.: Complement components in cystic fibrosis. Lancet 1974 II, 520–521

    Google Scholar 

  16. Hansson, L. O., Kjellman, N.-I. M., Leijon, I.: Complement in bronchial asthma. Lancet 1975 II, 874

  17. Harper, B. L., Carson, S. D., McNeely, C. M., Barnett, D. R., Bowman, B. H.: Immunologic and electrophoretic studies of the cystic fibrosis ciliary inhibitor. Cystic Fibrosis Club Abstracts 17th Ann. Meeting, p. 20. Cystic Fibrosis Foundation 1976

  18. Høiby, N., Andersen, V., Bendixen, G.: Pseudomonas aeruginosa infection in cystic fibrosis. Acta path. microbiol. scand. Sect. C 83, 459–468 (1975)

    Google Scholar 

  19. Holzhauer, R. J., Van Ess, J. D., Schwartz, R. H.: Third component of complement (C3) in cystic fibrosis. Cystic Fibrosis Club Abstracts 17th Ann. Meeting, p. 22. Cystic Fibrosis Foundation 1976

  20. Johnston, R. B., Stroud, R. M.: Complement and host defense against infection. J. Pediatr. 90, 169–179 (1977)

    Google Scholar 

  21. Kay, A. B., Bacon, G. D., Mercer, B. A., Simpson, H., Crofton, J. W.: Complement components and IgE in bronchial asthma. Lancet 1974 II, 916–920

    Google Scholar 

  22. Lederberg, S., Sackett, D.: Distribution of complement C3 variants in individuals with cystic fibrosis. Am. J. Hum. Genet. 28, 597–601 (1976)

    Google Scholar 

  23. Lieberman, J.: Carboxypeptidase B-like activity and C3 in cystic fibrosis. Am. Rev. Respir. Dis. 111, 100–102 (1975)

    Google Scholar 

  24. McFarlane, H., Holzel, A., Brenchley, P., Allan, J. D., Wallwork, J. C., Singer, B. E., Worsley, B.: Immune complexes in cystic fibrosis. Brit. Med. J. 1975 I, 423–428

  25. Osofsky, S. G., Thompson, B. H., Lint, T. F., Gewurz, H.: Hereditary deficiency of the third component of complement in a child with fever, skin rash, and arthralgias: Response to transfusion of whole blood. N. Engl. J. Med. 90, 180–186 (1977)

    Google Scholar 

  26. Palmer, D. G.: Complement and the clinician. Aust. N.Z. J. Med. 6, 349–356 (1976)

    Google Scholar 

  27. Polmar, S. H.: Immunodeficiency and pulmonary disease. In: Immunologic and infectious Reactions in the Lung (eds. C. H. Kirkpatrick, H. Y. Reynolds), pp. 191–209. New York-Basel: Marcel Dekker 1976

    Google Scholar 

  28. Rossman, C., Dolovich, J., Dolovich, M., Wilson, W., Newhouse, M.: Cystic fibrosis-related inhibition of mucociliary clearance in vivo in man. J. Pediatr. 90, 579–584 (1977)

    Google Scholar 

  29. Roy, C. C., Silverman, A., Cozzetto, F. J.: Pediatric Clinical Gastroenterology, p. 623. Saint Louis: C. V. Mosby 1975

    Google Scholar 

  30. Scanlin, T. F., Norman, M. E., Rosenlund, M. L.: C3 in cystic fibrosis. Lancet 1974 I, 1382

  31. Stephan, U., Busch, E.-W., Kollberg, H., Hellsing, K.: Cystic fibrosis: Detection by means of a test strip. Pediatrics 55, 35–38 (1975)

    Google Scholar 

  32. Taussig, L. M., Strunk, R. C., Sieber, O. F.: Depression of serum complement during viral lower respiratory tract illnesses (LRI) in cystic fibrosis (CF). Cystic Fibrosis Club Abstracts, 17th Ann. Meeting, p. 21. Cystic Fibrosis Foundation 1976

  33. Weeke, B., Flensborg, E. W., Jacobsen, L., Jørgensen, B. A., Lykkegaard, E., Høiby, N.: Immunochemical quantitation of 18 proteins in sera from patients with cystic fibrosis: Concentrations correlated to class of fibroblast metachromasia, clinical and radiological lung symptoms. Dan. Med. Bull. 23, 155–160 (1976)

    Google Scholar 

  34. Wood, R. E., Boat, T. F., Doershuk, C. F.: Cystic fibrosis. Am. Rev. Respir. Dis. 113, 833–878 (1976)

    Google Scholar 

  35. Wood, R. E., Wanner, A., Hirsch, J., Farrell, P. M.: Tracheal mucociliary transport in patients with cystic fibrosis and its stimulation by terbutaline. Am. Rev. Respir. Dis. 111, 733–738 (1975)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Paediatric University Hospital, Währing, Gürtel 74-76, A-1090, Vienna, Austria

    M. Götz & G. Lubec

Authors
  1. M. Götz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Lubec
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Dedicated to Professor E. Zweymüller on the occasion of his 60th birtday

Rights and permissions

Reprints and permissions

About this article

Cite this article

Götz, M., Lubec, G. Complement in cystic fibrosis. Eur J Pediatr 127, 133–139 (1978). https://doi.org/10.1007/BF00445769

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00445769

Key words

Search

Navigation